北米の変形性関節症治療市場の2030年までの予測 - 地域分析 - 治療タイプ別（経皮的電気神経刺激（TENS）、作業療法、理学療法、多血小板血漿療法および間質血管分画、プロロセラピーなど）、疾患適応症別（膝関節症、脊椎関節症、足関節症および足首関節症、肩関節症、手関節症など）、およびエンドユーザー別（病院および診療所、専門診療所、外来手術センター、在宅ケアなど）
より効果的な治療オプションが北米の変形性関節症治療市場を活性化
現在、OAを治す方法はありません。臨床研究科学者のグループは、臨床試験を通じて、OAの進行を止めることができる革新的な治療ターゲットオプションを開発していることを明らかにしています。たとえば、2021年11月、LG Chem社は関節炎を治療するための次世代新薬の臨床試験の開始を発表しました。さらに、2021年10月、Pacira BioSciences、Inc.は、非オピオイド鎮痛剤「ZILRETTA」を治療するためのFlexion Therapeuticsの買収を発表しました。 2017年に承認されたこの薬は、徐放性マイクロスフィア技術を利用したOA膝痛治療薬として初めて承認されたものです。
2023年9月、Sorrento Therapeutics, Inc.は、「Resiniferatoxin（RTX）プログラム」の第2相臨床試験で肯定的な結果を発表しました。第2相試験は、中等度から重度のOAK患者の疼痛管理におけるRTXの複数の投与量の有効性と安全性を評価する多施設、二重盲検、プラセボ、実薬対照試験です。また、Sorrentoは、承認済みの競合薬「Zilretta」を現在の臨床試験プロトコルに含めることを決定しました。
北米の変形性関節症治療市場の概要
北米の変形性関節症治療市場は、米国、カナダ、メキシコに区分されています。米国食品医薬品局（FDA）による変形性関節症治療薬の迅速な製品発売と、製品発売の加速に対する政府の支援は、市場の成長に最も影響を与える要因です。米国疾病管理予防センター（CDC）の報告書で明らかにされた統計によると、変形性関節症（OA）は最も一般的な関節炎であり、3,250万人の米国成人が罹患しています。さらに、変形性関節症（OA）アクションアライアンスの報告書によると、米国におけるOAに関連する全体的な経済的負担は年間1,368億ドルと推定されています。さらに、米国レントゲン線学会のARRS報告書によると、OAの生涯リスクは50％であり、2040年までに約7,800万人（26％）の米国成人がOAを患うと推定されています。
さらに、OAの痛みに対する非薬物療法を目指すメーカーによる新製品の承認は、市場の成長にさらに影響を与えます。たとえば、2021年6月、CyMedica Orthopedicsは、米国食品医薬品局（USFDA）から膝の変形性関節症の痛みに対する非侵襲的治療法「Intellihab System」の承認を受けたと発表しました。この新製品は、衰弱性変形性関節症によるOAの痛みを治療するために設計された治療およびデジタルベースのエコシステムです。したがって、治療薬への依存を減らすことに焦点を当てたOAの痛みを対象とした新しい非薬理学的療法は、変形性関節症治療市場の成長を促進する重要な要因です。
北米の変形性関節症治療市場の収益と2030年までの予測（百万米ドル）
北米の変形性関節症治療市場のセグメンテーション
北米の変形性関節症治療市場は、治療タイプ、疾患の適応症、エンドユーザー、および国に分類されています。
治療の種類に基づいて、北米の変形性関節症治療市場は、経皮的電気神経刺激（TENS）、作業療法、理学療法、多血小板血漿（PRP）療法および間質血管分画、プロロセラピーなどに分類されています。理学療法セグメントは、2022年に最大の市場シェアを占めました。
疾患の適応症の面では、北米の変形性関節症治療市場は、膝関節症、脊椎関節症、足と足首の変形性関節症、肩関節症、手の変形性関節症などに分類されています。膝関節炎セグメントは、2022年に北米の変形性関節症治療市場で最大のシェアを占めました。
エンドユーザーに基づいて、北米の変形性関節症治療市場は、病院と診療所、専門診療所、外来手術センター、在宅ケアなどに分類されます。在宅ケアセグメントは、2022年に北米の変形性関節症治療市場で最大のシェアを占めました。
国別に見ると、北米の変形性関節症治療市場は、米国、カナダ、メキシコに分割されています。2022年には、米国が北米の変形性関節症治療市場シェアを独占しました。
Vision Quest Industries Inc、Dr PRP USA LLC、Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc、およびMedi GmbH＆Co KGは、北米の変形性関節症治療市場で事業を展開している大手企業の一部です。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. North America Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - North America Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. North America Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Osteoarthritis Therapy Market - Country Analysis
10.1 North America Market Overview
10.1.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Vision Quest Industries Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Dr PRP USA LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Zimmer Biomet Holdings Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 DePuy Synthes Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bioventus Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Omron Healthcare Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Exactech Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medi GmbH & Co KG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Insight Partners
List of Tables
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Organic Developments Done by Companies
Table 13. Inorganic Developments Done by Companies
List of Figures
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Osteoarthritis Therapy Market by Key Countries - Revenue (2022) US$ Million
Figure 26. North America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Osteoarthritis Therapy market
1. Vision Quest Industries Inc
2. Dr PRP USA LLC
3. Zimmer Biomet Holdings Inc
4. DePuy Synthes Inc
5. Bioventus Inc
6. Omron Healthcare Inc
7. Exactech Inc
8. Medi GmbH & Co KG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America osteoarthritis therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America osteoarthritis therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.